Corticosteroids and Leukotrienes: Chronobiology and Chronotherapy

References

• Asano K, Lilly C, O'Donnell W J, et al. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. J Allergy Clin Immunol 1995; 96: 643–51
   PubMed Web of Science ®Google Scholar
• Bagg L R, Hughes D TD. Diurnal variation in peak expiratory flow in asthmatics. Eur J Respir Dis 1980; 61: 298–302
   PubMedGoogle Scholar
• Barnes P, Fitzgerald G, Brown M, et al. Nocturnal asthma and changes in circulating epinephrine, histamine and Cortisol. N Engl J Med 1980; 303: 263–67
   PubMed Web of Science ®Google Scholar
• Beam W R, Ballard R D, Martin R J. Spectrum of corticosteroid sensitivity in nocturnal asthma. Am Rev Respir Dis 1992; 145: 1082–86
   PubMedGoogle Scholar
• Beam W R, Weiner D E, Martin R J. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992; 146: 1524–30
   PubMedGoogle Scholar
• Bellia V, Bonanno A, Cibella F, et al. Urinary leukotriene E4 in the assessment of nocturnal asthma. J Allergy Clin Immunol 1996; 97: 735–41
   PubMed Web of Science ®Google Scholar
• Bray M A. The pharmacology and pathophysiology of leukotriene B4. Br Med Bull 1983; 39: 249–54
   PubMed Web of Science ®Google Scholar
• Busse W W. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996; 26: 868–79
   PubMed Web of Science ®Google Scholar
• Cochrane G M, Clark T JH. A survey of asthma mortality in patients between ages 35 and 65 in the greater London hospitals in 1971. Thorax 1975; 30: 300–15
   PubMed Web of Science ®Google Scholar
• Dahlen S E, Hedqvist P, Hammarstrom S, et al. Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288: 484–86
   PubMed Web of Science ®Google Scholar
• Dethlefsen U, Repgas R. Ein neues therapieprinzip bei nachtilchen asthma. Klin Med 1985; 80: 44–47
   Google Scholar
• deVries K, Goei J T, Booy-Noord H, et al. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bron-chitic patients. Int Arch Allergy 1962; 20: 93–101
   Google Scholar
• Floyer J. A treatise of the asthma. R. Witkin and W. Inngs, London 1698; 7–8
   Google Scholar
• Gaultier C, DeMontis G, Reinberg A. Circadian rhythm of serum total immunoglobulin E (IgE) of asthmatic children. Biomed Pharmacother 1987; 41: 186–88
   PubMedGoogle Scholar
• Gervais P, Reinberg A, Gervais C, et al. Twenty-four-hour rhythm in the bronchial hyperreactivity to house dust in asthmatics. J Allergy Clin Immunol 1977; 59: 207–13
   PubMedGoogle Scholar
• Hetzel M R, Clark T JH, Braithwaite M A. Analysis of sudden deaths and ventilatory arrests in hospital. Br Med J 1977; 1: 808–11
   PubMed Web of Science ®Google Scholar
• Kraft M, Pak J, Martin R J. Serum Cortisol in asthma: marker of nocturnal worsening of lung function. Chronobiol Int 1998; 15: 85–92
   PubMed Web of Science ®Google Scholar
• Kraft M, Vianna E O, Martin R JM, et al. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and reduced steroid responsiveness. J Allergy Clin Immunol 1999; 103: 66–71
   PubMedGoogle Scholar
• Morrison J FJ, Pearson S B, Dean H G. Parasympathetic nervous system in nocturnal asthma. Br Med J 1988; 296: 1427–29
   PubMed Web of Science ®Google Scholar
• Palmblad J, Malmsten C L, Uden A M, et al. Leukotriene B4 is a potent and stereo-specific stimulator of neutrophil chemotaxis and adherence. Blood 1981; 58: 658–61
   PubMed Web of Science ®Google Scholar
• Pincus D J, Humeston T R, Martin R J. Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1997; 100: 771–74
   PubMed Web of Science ®Google Scholar
• Pincus D J, Szefler S J, Ackerson L M, et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995; 95: 1171–78
   Google Scholar
• Reinberg A, Gervais P, Chaussade M, et al. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol 1983; 71: 425–33
   PubMed Web of Science ®Google Scholar
• Reinberg A, Halberg F, Falliers J. Circadian timing of methylprednisolone effects in asthmatic boys. Chronobiol Int 1974; 1: 333–47
   Google Scholar
• Rigas B, Levine L. Human salivary eicosanoids: circadian variation. Biochem Bio-phys Res Commun 1983; 115: 201–5
   PubMedGoogle Scholar
• Robertson C F, Rubinfeld A R, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Aust 1990; 152: 511–17
   PubMed Web of Science ®Google Scholar
• Salter H H. Asthma: its pathology and treatment. 1st American ed. Wood, New York 1882
   Google Scholar
• Smolensky M H, Barnes P J, Reinberg A, et al. Chronobiology and asthma. I. Day-night differences in bronchial patency and dyspnea and circadian rhythm dependencies. J Asthma 1986; 23(6)321–43
   PubMed Web of Science ®Google Scholar
• Soutar C A, Costello J, Ijaduola O, et al. Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to Cortisol infusion. Thorax 1975; 30: 436–40
   PubMed Web of Science ®Google Scholar
• Spector S L, Smith L J, Glass M, et al. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med 1994; 150: 618–23
   PubMed Web of Science ®Google Scholar
• Storms W W, Bodman S F, Nathan R A, et al. Nocturnal asthma symptoms may be more prevalent than we think. J Asthma 1994; 31: 313–18
   PubMed Web of Science ®Google Scholar
• Tammeling G J, DeVries K, Kruyt E W. The circadian pattern of bronchial reactivity to histamine in healthy subjects and in patients with obstructive lung disease. Chronobiology in allergy and immunology, M H Smolensky, A E Reinberg, J P McGovern. Charles C Thomas, Springfield, Illinois 1997; 139–50
   Google Scholar
• Toogood J H, Baskerville J C, Jennings B, et al. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982; 70: 288–98
   PubMed Web of Science ®Google Scholar
• Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85: 6–8
   PubMed Web of Science ®Google Scholar
• Wenzel S E, Trudeau J B, Kaminsky D A, et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152: 897–905
   PubMed Web of Science ®Google Scholar
• Wenzel S E, Trudeau J B, Westcott J Y, et al. Single oral dose of prednisone decreases leukotriene B4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: relationship to changes in cellular influx and FEV1. J Allergy Clin Immunol 1994; 94: 870–81
   PubMedGoogle Scholar